 Panbela Therapeutics Inc NASDAQ: PBLA has agreed to acquire a privately-held Cancer Prevention Pharmaceuticals Inc CPP for a combination of stock and future milestone payments. The combined entity will have an expanded pipeline addressing an estimated 5 billion market. 